MNX Market Network Exchange
Commercial intelligence · New York
Menu
$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

New York policy

A6927: Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

NY Assembly · Sponsor Tony Simone

Jurisdiction
New York State
Applies to
New York State (proposed)
Effective
May 28, 2026

What it requires

Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.

ny-stateassemblylegislationbill

Official source ↗

Free account

Create a free account

Track New York policy and save searches across the Network. Free. No card required.

Want to turn policy like this into market and network moves? Build your Market Network Strategic Plan →